The University of Pennsylvania’s Stephen Bagley, MD, MSCE, discussed liquid biopsy for brain tumors and its potential to assess the tumor immune environment and guide patient selection for immunotherapies.
On Wednesday, June 24, Cancer Research Institute CEO Jill O’Donnell-Tormey, PhD, and the Foundation’s Chief Scientific Officer Jessica Foley, PhD, discussed cancer immunotherapy in the time of COVID-19.
The Ferenc Jolesz Memorial Award honors a world-class visionary while recognizing and encouraging Dr. Jolesz's innovative spirit in a mid-career researcher in focused ultrasound.
A 67-year-old male with stage 4 colon cancer underwent histotripsy-mediated ablation and noticed a significant reduction in tumors outside the treatment area.
Yekaterina “Katya” Gilbo recently completed her work on a Foundation-sponsored focused ultrasound thermometry project and earned her MS degree in Biomedical Engineering.
Hong Chen's team at Washington University in St. Louis has published new parameters for using focused ultrasound to improve the biomarker yield when conducting liquid biopsy for brain tumors.
“From Talk to Action: Canadian Leadership Ethics and Neurotechnology” was the theme of the recent Pan Canada Neurotechnology Ethics Collaborative’s virtual workshop.
PI Ceramic is a German company that fabricates one of the most critical parts of a focused ultrasound – or any type of ultrasound – machine: the piezoceramic elements that vibrate to produce the ultrasound.
Dr. G. Rees Cosgrove and Dr. Leo Verhagen discussed their clinical experiences implementing an incisionless surgery program to treat movement disorders in the recent webinar, "From Launch to 100 Treatments."
SonALAsense was a winner in the Center for Advancing Innovation’s “Brain Race,” an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors.
